PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.12%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.85%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-18.15%
Negative EBIT growth while EXP is at 10269.28%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-18.15%
Negative operating income growth while EXP is at 10269.28%. Joel Greenblatt would press for urgent turnaround measures.
-18.18%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-13.29%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.46%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-3.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.78%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-36.67%
Dividend reduction while EXP stands at 0.24%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
20.40%
OCF growth above 1.5x EXP's 8.91%. David Dodd would confirm a clear edge in underlying cash generation.
20.85%
FCF growth 1.25-1.5x EXP's 15.69%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.08%
Inventory is declining while EXP stands at 10.77%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-2.35%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-1.05%
We have a declining book value while EXP shows 3.78%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
9.58%
We have some new debt while EXP reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-42.94%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.